| Title |
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)
|
|---|---|
| Published in |
Patient preference and adherence, December 2022
|
| DOI | 10.2147/ppa.s379065 |
| Pubmed ID | |
| Authors |
Marina B Klein, Jim Young, David Ortiz-Paredes, Shouao Wang, Sharon Walmsley, Alexander Wong, Valérie Martel-Laferrière, Neora Pick, Brian Conway, Jonathan Angel, Jean-Guy Baril, Chris Fraser, Bertrand Lebouché, Darrell H S Tan, Roger Sandre, Sylvie Trottier, Hansi Peiris, Jayamarx Jayaraman, Joel Singer, On behalf of the CTN 286 Study Investigators |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 50% |
| United States | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 22 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 2 | 9% |
| Student > Bachelor | 2 | 9% |
| Unspecified | 1 | 5% |
| Professor > Associate Professor | 1 | 5% |
| Student > Ph. D. Student | 1 | 5% |
| Other | 2 | 9% |
| Unknown | 13 | 59% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 3 | 14% |
| Medicine and Dentistry | 3 | 14% |
| Economics, Econometrics and Finance | 1 | 5% |
| Neuroscience | 1 | 5% |
| Immunology and Microbiology | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 13 | 59% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2022.
All research outputs
#16,387,941
of 25,872,466 outputs
Outputs from Patient preference and adherence
#921
of 1,769 outputs
Outputs of similar age
#242,678
of 492,510 outputs
Outputs of similar age from Patient preference and adherence
#16
of 35 outputs
Altmetric has tracked 25,872,466 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,769 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 492,510 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.